| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07634848 Ivarmacitinib for Refractory Behcet's Syndrome | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07451665 | Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active… | Takayasu Arteritis (TAK) | Not Yet Recruiting |
| NCT07452445 | Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR… | Rheumatoid Arthritis | Not Yet Recruiting |
| Phase 2 | |||
| NCT07313202 | Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory… | Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE | Not Yet Recruiting |
| NCT07634848 | Ivarmacitinib for Refractory Behcet's Syndrome | Behcet's Syndrome | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07381114 | A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After… | aGVHD | Not Yet Recruiting |